Veterinary drug, 17β-trenbolone promotes the proliferation of human prostate cancer cell line through the Akt/AR signaling pathway. (May 2018)
- Record Type:
- Journal Article
- Title:
- Veterinary drug, 17β-trenbolone promotes the proliferation of human prostate cancer cell line through the Akt/AR signaling pathway. (May 2018)
- Main Title:
- Veterinary drug, 17β-trenbolone promotes the proliferation of human prostate cancer cell line through the Akt/AR signaling pathway
- Authors:
- Lee, Hee-Seok
Jung, Da-Woon
Han, Songyi
Kang, Hui-Seung
Suh, Jin-Hyang
Oh, Hyun-Suk
Hwang, Myung-Sil
Moon, Guiim
Park, Yooheon
Hong, Jin-Hwan
Koo, Yong Eui - Abstract:
- Abstract: Trenbolone acetate (TBA) is a synthetic anabolic steroidal growth factor that is used for rapid muscle development in cattle. The absorbed TBA is hydrolyzed to the active form, 17β-trenbolone (17 TB; 17β-hydroxy-estra-4, 9, 11-trien-3-one) in meat and milk products, which can cause adverse health effects in humans. Similar to 5α-dihydrotestosterone (DHT), 17 TB was reported to exhibit endocrine disrupting effects on animals and humans due to its androgenic effect via binding to the androgen receptor. The purpose of this study is to investigate the molecular mechanism of cell proliferation in prostate cancer (PCa) cells treated with 17 TB. We found that 17 TB induces AR-dependent cell proliferation in the human prostate cancer cell line, 22Rv1 in a concentration dependent manner. Treatment with 17 TB increased the expression of cell cycle regulatory proteins, cyclin D2/CDK-4 and cyclin E/CDK-2, whereas the expression of p27 was down-regulated. Furthermore, phosphorylation of Rb and activation of E2F were also induced, which suggests the activation of cyclin D2/CDK-4 and cyclin E/CDK-2 in the cells. When 22Rv1 cells were exposed to 30 pM of 17 TB, which is the effective concentration (EC50 ) value required to observe proliferative effects on 22Rv1 cells, the expression levels of the phosphorylated forms of Akt and GSK3β were increased. This study demonstrates that 17 TB induces AR-dependent proliferation through the modulation of cell cycle-related proteins in theAbstract: Trenbolone acetate (TBA) is a synthetic anabolic steroidal growth factor that is used for rapid muscle development in cattle. The absorbed TBA is hydrolyzed to the active form, 17β-trenbolone (17 TB; 17β-hydroxy-estra-4, 9, 11-trien-3-one) in meat and milk products, which can cause adverse health effects in humans. Similar to 5α-dihydrotestosterone (DHT), 17 TB was reported to exhibit endocrine disrupting effects on animals and humans due to its androgenic effect via binding to the androgen receptor. The purpose of this study is to investigate the molecular mechanism of cell proliferation in prostate cancer (PCa) cells treated with 17 TB. We found that 17 TB induces AR-dependent cell proliferation in the human prostate cancer cell line, 22Rv1 in a concentration dependent manner. Treatment with 17 TB increased the expression of cell cycle regulatory proteins, cyclin D2/CDK-4 and cyclin E/CDK-2, whereas the expression of p27 was down-regulated. Furthermore, phosphorylation of Rb and activation of E2F were also induced, which suggests the activation of cyclin D2/CDK-4 and cyclin E/CDK-2 in the cells. When 22Rv1 cells were exposed to 30 pM of 17 TB, which is the effective concentration (EC50 ) value required to observe proliferative effects on 22Rv1 cells, the expression levels of the phosphorylated forms of Akt and GSK3β were increased. This study demonstrates that 17 TB induces AR-dependent proliferation through the modulation of cell cycle-related proteins in the Akt signaling pathway. The present study provides an effective methodology for identifying cell proliferation signaling of veterinary drugs that exert AR agonistic effects. Highlights: 17 TB is hydrolyzed form of veterinary drug, Trenbolone acetate. 17 TB residues in meat and milk products could cause adverse effects in humans. We found mechanism of proliferation of human prostate cancer cell, 22Rv1 by 17 TB. 17 TB promotes the proliferation of 22Rv1 line through Akt/AR signaling pathway. … (more)
- Is Part Of:
- Chemosphere. Volume 198(2018)
- Journal:
- Chemosphere
- Issue:
- Volume 198(2018)
- Issue Display:
- Volume 198, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 198
- Issue:
- 2018
- Issue Sort Value:
- 2018-0198-2018-0000
- Page Start:
- 364
- Page End:
- 369
- Publication Date:
- 2018-05
- Subjects:
- Veterinary drugs -- 17β-trenbolone -- Androgen receptor -- Cell proliferation -- Prostate cancer
Pollution -- Periodicals
Pollution -- Physiological effect -- Periodicals
Environmental sciences -- Periodicals
Atmospheric chemistry -- Periodicals
551.511 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00456535/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.chemosphere.2018.01.145 ↗
- Languages:
- English
- ISSNs:
- 0045-6535
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.280000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 11332.xml